Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Rafael Holdings, Inc. (RFL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/02/2023 8-K Quarterly results
04/04/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Rafael Holdings Announces up to $5 Million Share Repurchase Program"
02/02/2023 8-K Quarterly results
01/26/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
01/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/13/2022 8-K Quarterly results
11/15/2022 8-K Quarterly results
10/31/2022 8-K Quarterly results
08/23/2022 8-K Quarterly results
07/01/2022 8-K Quarterly results
06/14/2022 8-K Quarterly results
05/31/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
03/17/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Rafael Holdings Reports Second Quarter Fiscal 2022 Financial Results"
02/28/2022 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review &nbsp...
02/02/2022 8-K Quarterly results
01/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "VIA EMAIL William Conkling 110 Woods End Drive Basking Ridge, NJ 07920 [email protected] Dear Bill, It is our pleasure to offer you continued employment at Rafael Holdings, Inc. in accordance with the terms and conditions provided herein. Effective February 1, 2022 , the Employment Agreement between you and the Company dated as of March 7, 2021 shall terminate and be of no further force and effect and shall be superseded and replaced in its entirety by this letter agreement , which outlines the terms of your continued employment at the Company as follows: 1. Position and Duties : From and after the Effective Date, you will be employed as the Chief Executive Officer of the Company , which shall be an executive officer position with the Company, and in that role you will ov...",
"# # #"
12/15/2021 8-K Quarterly results
11/22/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "VIA EMAIL Patrick Fabbio [email protected] Dear Pat, As you are aware, you and Rafael Holdings, Inc. entered into a letter agreement dated September 10, 2021 related to your employment by the Company. The purpose of this letter is to amend the Letter Agreement and your terms of employment, effective as of November 21, 2021 , as follows: 1. As of the Effective Date, you will be the President and Chief Financial Officer of the Company, which shall be an executive officer position with the Company, and in that role you will be responsible for business and financial aspects of the operations of the company and its subsidiaries and controlled affiliates. 2. The third sentence of Section 5 of the Letter Agreement shall be amended to read in its entirety: The vesting schedule shal...",
"# # #"
10/28/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Rafael Holdings Provides Update on Rafael Pharmaceuticals’ Two Phase 3 Trials of CPI-613 , AVENGER 500 in Metastatic Pancreatic Cancer and ARMADA 2000 in Relapsed or Refractory Acute Myeloid Leukemia"
10/18/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "RAFAEL HOLDINGS, INC. CONSOLIDATED BALANCE SHEETS July 31, July 31, 2021 2020 ASSETS CURRENT ASSETS Cash and cash equivalents $ 7,854 $ 6,206 Restricted cash 5,000 - Trade accounts receivable, net of allowance for doubtful accounts of $193 and $218 at July 31, 2021 and 2020, respectively 235 267 Due from Rafael Pharmaceuticals 600 118 Prepaid expenses and other current assets 1,075 273 Assets held for sale 0 2,968 Total current assets 14,764 9,832 Property and equipment, net 43,238 44,433 Equity investment – RP Finance 575 192 Due from RP Finance LLC 7,500 - Investments – Rafael Pharmaceuticals 79,141 70,018 Investments – Other Pharmaceuticals 477 1,201 Investments – Hedge Funds 5,268 7,510 Deferred income tax assets, net 0 6 In-process research and development and patents 1,575 1,575 Othe..."
10/05/2021 8-K Other Events  Interactive Data
09/24/2021 8-K Quarterly results
09/14/2021 8-K Quarterly results
08/24/2021 8-K Quarterly results
08/10/2021 8-K Quarterly results
07/15/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Loan Agreement by and between the Registrant, Rafael Holdings Realty, Inc., Broad-Atlantic Associates, LLC and 520 Broad Street LLC"
07/09/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Investor Presentations"
06/21/2021 8-K Quarterly results
06/21/2021 8-K Quarterly results
06/14/2021 8-K Quarterly results
03/17/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results"
03/11/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy